Group sham | Group shock-40 | Group shock-30 | |
---|---|---|---|
MDA (Mean ± SD, μmol/mL) | |||
Baseline | 0.61 ± 0.16 | 0.81 ± 0.15a | 0.69 ± 0.07c, e |
End of shock | 0.88 ± 0.09 | 1.77 ± 0.09b | 1.69 ± 0.04d, e |
30 min | 1.04 ± 0.27 | 2.32 ± 0.12b | 2.16 ± 0.08d, e |
60 min | 1.14 ± 0.34 | 2.61 ± 0.19b | 2.65 ± 0.06d, e |
90 min | 1.26 ± 0.40 | 2.85 ± 0.22b | 2.79 ± 0.67d, e |
120 min | 1.36 ± 0.49 | 3.23 ± 0.19b | 3.20 ± 0.09d, e |
TAS (Mean ± SD, μmol/L) | |||
Baseline | 0.59 ± 0.11 | 0.47 ± 0.14a | 0.39 ± 0.08c, e |
End of shock | 0.70 ± 0.12 | 0.80 ± 0.19a | 0.75 ± 0.13c, e |
30 min | 0.73 ± 0.11 | 0.86 ± 0.18a | 0.77 ± 0.09c, e |
60 min | 0.77 ± 0.10 | 0.75 ± 0.16a | 0.61 ± 0.13c, e |
90 min | 0.79 ± 0.11 | 0.59 ± 0.08b | 0.55 ± 0.10d, e |
120 min | 0.77 ± 0.08 | 0.49 ± 0.01b | 0.47 ± 0.08d, e |
LPS (Median-range, EU/mL) | |||
Baseline | 0.26 (0.05–0.56) | 0.39 (0.05–4.18)a | 0.05 (0.05–1.38)c, e |
End of shock | 0.10 (0.05–0.13) | 0.57 (0.13–1.65)b | 0.05 (0.05–0.85)c, e |
30 min | 0.05 (0.05–0.17) | 0.32 (0.05–0.56)a | 0.05 (0.05–0.96)c, e |
60 min | 0.05 (0.05–0.48) | 0.24 (0.06–0.49)a | 0.14 (0.05–0.89)c, e |
90 min | 0.05 (0.05–0.54) | 0.60 (0.05–1.23)a | 0.05 (0.05–1.45)c, e |
120 min | 0.05 (0.05–0.46) | 0.42 (0.05–1.58)a | 0.05 (0.05–8.38)c, e |